Anti-Atherosclerotic Properties of Nifedipine

Cardiology (Switzerland)

Volumn 88, Issue , 1997, Pages 52-55

  Rafflenbeul, W ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Acute coronary syndromes; Atherogenesis; Early coronary lesion; Nifedipine; Prognosis

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; NIFEDIPINE;

ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CONFERENCE PAPER; CORONARY ARTERY DISEASE; HEART MUSCLE ISCHEMIA; PRIORITY JOURNAL;

ACUTE DISEASE; ANIMALS; ARTERIOSCLEROSIS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY VESSELS; HUMANS; NIFEDIPINE; PROGNOSIS;

EID: 0030824980     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177508     Document Type: Article

References (46)

1. Slary HC: Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989: 99(suppl I):I-19-I-32.
2. Clarkson TB. Prichard RW. Morgan TM, et al: Remodeling of coronary arteries in human and nonhuman primates (comments). JAMA 1994; 271:289-294.
3. Glagov S. Weisenbcrg E. Zarins C. et al: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987:316: 371-375.
4. Armstrong ML. Megan MB, Heistad DD: Adaptive responses of the artery wall as human atherosclerosis develops: in Glagov S. Newman WP. Schaffer SA (eds): Pathobiology of the Human Atherosclerotic Plaque. New York, Springer. 1989; pp 469-480.
5. Fuster V. Badimon L. Badimon J, et al: The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992: 326:242-250.
6. Chesebro JH, Webster MWI. Zoldhelyi P. et al: Antithrombotic therapy and progression of coronary' artery disease. Circulation 1992; 86(suppl III):III-110-III-111.
7. Ntssen SE. Gurley JC, Grines CL, et al: Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation 1991:84:1087-1099.
8. Ge J. Erbel R, Gerber T, et al: Intravascular ultrasound imaging of angiographically normal coronary arteries: A prospective study in vivo. Br Heart J 1994:71:572-578.
9. St Gear FG, Pinto FJ, Alderman EL, et al: Intravascular ultrasound imaging of angiographically normal coronary arteries: An in vivo comparison with quantitative angiography. J Am Coll Cardiol 1991;18:952-958.
10. Fuster V. Lewis A: Mechanisms leading to myocardial infarction: Insights from studies of vascular biology (review). Circulation 1994:90: 2126-2146.
11. Hackctt D. Davies G. Maseri A: Pre-existing coronary stenoses in patients with first myocar-idal infarction arc not necessarily severe. Eur Heart J 1988;9:1317-1323.
12. Ambrose JA. Tannenbaum MA. Alexopoulos D, et al: Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12:56-62.
13. Nobuyoshi M. Tanaka M. Nosaka H, et al: Progression of coronary atherosclerosis: Is coronary spasm related to progression? J Am Coll Cardiol 1991;18:904-910.
14. Giroud D, Li JMM. Urban P. et al: Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography (comments). Am J Cardiol 1992; 69:729-732.
15. Brown BG, Gallery CA, Badger RS, et al: Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase of acute myocardial infarction: Quantitative angiographic observations. Circulation 1986:73: 653-661.
16. 4S-Study: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994:344:1383-1389.
17. Davies MJ. Thomas AC: Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985:53:363-373.
18. Richardson PD. Davies MJ. Born GV: Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989;ii:941-944.
19. Loree HM, Kamm RD. Stringfellow RG. et al: Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Ciré Res 1992;71:850-858.
20. Davies MJ: Detecting vulnerable coronary' plaques. Commentary. Lancet 1996:347:1422.
21. Hangartner JRW. Charleston AJ. Davies MJ, et al: Morphological characteristics of clinically significant coronary artery stenosis in stable angina. Br Heart J 1986;56:501-508.
22. Maclsaac AI, Thomas JD. Topol EJ: Toward the quiescent coronary plaque. J Am Coll Cardiol 1993;22:1228-1241.
23. Henry PD: Athcrogenesis, calcium and calcium-antagonist. Am J Cardiol 1990:66:31-71.
24. 0 on electrical activity of clusters of cultured cardiac cells from neonatal rats. J Mol Cell Cardiol 1979;11:477-484.
25. Ross RN: The pathogenesis of atherosclerosis. N Engl J Med 1986;314:488-490.
26. Metha J. Metha P. Ostrowski N. et al: Effects of verapamil on platelet aggregation. ATP release and thromboxane generation. Thromb Res 1983;30:469-475.
27. Strickbcrger SA, Russek LN, Phair RD: Evidence for increased aortic plasma membrane calcium transport caused by experimental atherosclerosis in rabbits. Circ Res 1988:62:75-80.
28. Nakao J, Ito H. Ooyama T. et al: Calcium dependency of aortic smooth muscle cell migration induced by 12-L-hydroxy-5,8,10,14-ei-cosatetraenoic acid. Atherosclerosis 1983:46: 309-319.
29. Metcalfe JC. Moore JP. Smith GA, et al: Calcium and cell proliferation. Br Med Bull 1986: 42:405-412.
30. Van Houtte PM: Ca++-antagonistsand vascular disease. Ann NY Acad Sci 1988;522:380-389.
31. Strohschneidcr T, Betz E: Densitometric measurement of increased endothelial permeability in arteriosclerotic plaques and inhibition of permeability under the influence of two calcium-antagonists. Atherosclerosis 1989;75: 135-144.
32. Johnsson H: Effects by nifedipine on platelet function in vitro and in vivo. Thromb Res 1981;21:523-528.
33. Baldcnkov GN. Akopov SE. Ryong LH. et al: Prostacyclin, thromboxane A2 and calcium-antagonists: Effects on atherosclerotic characteristics of vascular cells. Biomed Biochim Acta 1988;47:324-327.
34. Block LH, Emmons LR, Vogt E, et al: Ca++-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells. Proc Natl Acad Sci USA 1989;86:2388-2392.
35. Nilsson J, Sjolund M. Palmberg L, et al: The calcium-antagonist nifedipine inhibits arterial smooth muscle cell proliferation. Atherosclerosis 1985;58:109-112.
36. Nomoto A. Mutoh S, Hagihara H, et al: Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium-antagonist, nivaldipine. Atherosclerosis 1988:72:213-219.
37. Etingin OR. Hajjar DJ: Calcium channel blockers enhance cholesterol ester hydrolysis and decrease total cholesterol accumulation in human aortic tissue. Circ Res 1990:66:185-190.
38. Ellis S, Sanders W. Goulet C. et al: Optimal detection of the progression of coronary artery disease: Comparison of methods suitable for risk factor intervention trials. Circulation 1986;74:1235-1242.
39. MAAS Investigators: Effect of simvastatin on coronary atheroma: The Multicentre Anti-Atheroma Study (MAAS). Lancet 1994:344: 633-638.
40. Waters D, Craven TE, Lesperance, I: Prognostic significance of progression of coronary atherosclerosis. Circulation 1993;87:1067-1075.
41. Lippolt P, Ehrhard K. Riedel M. et al: Variability in quantitative coronary angiography: Higher precision by analysis in consecutive frames. J Am Coll Cardiol 1994;23(suppl):209A.
42. Buchwald H, Matts JP. Fitch LL. et al: The Surgical Control of the Hyperlipidemias (POSCH) Group: Changes in sequential coronary arteriograms and subsequent coronary’ events. J.AMA 1987;257:3233-3240.
43. Arntzcnius AC. Kromhout D, Barth JD, et al: Diet, lipoproteins, and the progression of coronary atherosclerosis: The Leiden Intervention Trial. N Engl J Med 1985;312:805-811.
44. Brown BG, Albers JJ, Fisher LD. et al: Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990:323:1289-1298.
45. Watts GF. Lewis B. Brunt JNH, et al: Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas’ Atherosclerosis Regression Study (STARS). Lancet 1992;339:563-569.
46. Thompson GR: Angiographic trials of lipidlowering therapy: End of an era? Br Heart J 1995;74:343-347.